AbCellera Biologics Inc. Files 8-K
Ticker: ABCL · Form: 8-K · Filed: May 30, 2025 · CIK: 1703057
| Field | Detail |
|---|---|
| Company | Abcellera Biologics INC. (ABCL) |
| Form Type | 8-K |
| Filed Date | May 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: ABCL
TL;DR
AbCellera filed an 8-K on 5/30/25, standard stuff, check for details.
AI Summary
AbCellera Biologics Inc. filed an 8-K on May 30, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details on new events, agreements, or financial figures beyond its standard reporting nature.
Why It Matters
This 8-K filing indicates AbCellera Biologics Inc. has submitted a routine report to the SEC, which may contain updates or disclosures relevant to investors.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not appear to disclose any new material events or significant financial changes.
Key Players & Entities
- AbCellera Biologics Inc. (company) — Registrant
- May 30, 2025 (date) — Date of Report
- Vancouver, BC (location) — Registrant's principal executive office
FAQ
What is the primary purpose of this 8-K filing for AbCellera Biologics Inc.?
The filing is a Current Report on Form 8-K, reporting "Other Events" and "Financial Statements and Exhibits" as of May 30, 2025.
What is AbCellera Biologics Inc.'s principal executive office address?
The principal executive office is located at 150 W 4th Avenue, Vancouver, BC V5Y 1G6.
What is the telephone number for AbCellera Biologics Inc.?
The registrant's telephone number, including area code, is (604) 559-9005.
What is the Commission File Number for AbCellera Biologics Inc.?
The Commission File Number is 001-39781.
What is the fiscal year end for AbCellera Biologics Inc.?
The fiscal year end for AbCellera Biologics Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding AbCellera Biologics Inc. (ABCL).